These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

554 related articles for article (PubMed ID: 34351835)

  • 1. Therapeutic perspectives on the metabolism of lymphocytes in patients with rheumatoid arthritis and systemic lupus erythematosus.
    Iwata S; Tanaka Y
    Expert Rev Clin Immunol; 2021 Oct; 17(10):1121-1130. PubMed ID: 34351835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunometabolism and systemic lupus erythematosus].
    Xiao YB; Guo MY; Zuo XX
    Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Dec; 50(6):1120-1124. PubMed ID: 30562794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic dysregulation of lymphocytes in autoimmune diseases.
    Wang S; Yang N; Zhang H
    Trends Endocrinol Metab; 2024 Jul; 35(7):624-637. PubMed ID: 38355391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B-cell targeted therapies in rheumatoid arthritis and systemic lupus erythematosus.
    Eisenberg R; Albert D
    Nat Clin Pract Rheumatol; 2006 Jan; 2(1):20-7. PubMed ID: 16932648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunometabolism in systemic lupus erythematosus.
    Morel L
    Nat Rev Rheumatol; 2017 May; 13(5):280-290. PubMed ID: 28360423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Revealing the Immune Heterogeneity between Systemic Lupus Erythematosus and Rheumatoid Arthritis Based on Multi-Omics Data Analysis.
    Zhang Y; Lee TY
    Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural products action on pathogenic cues in autoimmunity: Efficacy in systemic lupus erythematosus and rheumatoid arthritis as compared to classical treatments.
    Cao F; Cheng MH; Hu LQ; Shen HH; Tao JH; Li XM; Pan HF; Gao J
    Pharmacol Res; 2020 Oct; 160():105054. PubMed ID: 32645358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of T cells in the pathogenesis of systemic lupus erythematous: Focus on immunometabolism dysfunctions.
    Saadh MJ; Kazemi K; Khorramdelazad H; Mousavi MJ; Noroozi N; Masoumi M; Karami J
    Int Immunopharmacol; 2023 Jun; 119():110246. PubMed ID: 37148769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Properties of SBI-087, a CD20-Directed B-cell Depleting Agent: Phase 1 Dose Escalating Studies in Patients With Either Mild Rheumatoid Arthritis or Systemic Lupus.
    Cohen S; Clowse M; Pardo P; Bhattacharya I; Menon S; Gourley I; Diehl A
    Clin Ther; 2016 Jun; 38(6):1417-1434.e2. PubMed ID: 27112532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B Cells in Systemic Lupus Erythematosus: From Disease Mechanisms to Targeted Therapies.
    Canny SP; Jackson SW
    Rheum Dis Clin North Am; 2021 Aug; 47(3):395-413. PubMed ID: 34215370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proinflammatory Differentiation of Macrophages Through Microparticles That Form Immune Complexes Leads to T- and B-Cell Activation in Systemic Autoimmune Diseases.
    Burbano C; Villar-Vesga J; Vásquez G; Muñoz-Vahos C; Rojas M; Castaño D
    Front Immunol; 2019; 10():2058. PubMed ID: 31555283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selfie: Autoimmunity, boon or bane.
    Ahsan H
    J Immunoassay Immunochem; 2017; 38(3):235-246. PubMed ID: 28421864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving B-cell depletion in systemic lupus erythematosus and rheumatoid arthritis.
    Mota P; Reddy V; Isenberg D
    Expert Rev Clin Immunol; 2017 Jul; 13(7):667-676. PubMed ID: 27841031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An updated advance of autoantibodies in autoimmune diseases.
    Xiao ZX; Miller JS; Zheng SG
    Autoimmun Rev; 2021 Feb; 20(2):102743. PubMed ID: 33333232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [B cell targeting therapy using the anti-CD20 antibody in autoimmune diseases].
    Tanaka Y
    Yakugaku Zasshi; 2009 Jun; 129(6):675-9. PubMed ID: 19483410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic alterations of the immune system in the pathogenesis of autoimmune diseases.
    Blanco LP; Kaplan MJ
    PLoS Biol; 2023 Apr; 21(4):e3002084. PubMed ID: 37098006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cellular overview of immunometabolism in systemic lupus erythematosus.
    Psarras A; Clarke A
    Oxf Open Immunol; 2023; 4(1):iqad005. PubMed ID: 37554724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B cell activation via immunometabolism in systemic lupus erythematosus.
    Iwata S; Hajime Sumikawa M; Tanaka Y
    Front Immunol; 2023; 14():1155421. PubMed ID: 37256149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased circulating CXCL13 levels in systemic lupus erythematosus and rheumatoid arthritis: a meta-analysis.
    Bao YQ; Wang JP; Dai ZW; Mao YM; Wu J; Guo HS; Xia YR; Ye DQ
    Clin Rheumatol; 2020 Jan; 39(1):281-290. PubMed ID: 31523787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pathological role of B cells in systemic lupus erythematosus: From basic research to clinical.
    Feng Y; Yang M; Wu H; Lu Q
    Autoimmunity; 2020 Mar; 53(2):56-64. PubMed ID: 31876195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.